These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33671516)

  • 1. Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways.
    Martin I; Waters V; Grasemann H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms.
    Luo Y; Yang Q; Zhang D; Yan W
    J Microbiol Biotechnol; 2021 Jan; 31(1):1-7. PubMed ID: 33323672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix exopolysaccharides; the sticky side of biofilm formation.
    Maunders E; Welch M
    FEMS Microbiol Lett; 2017 Jul; 364(13):. PubMed ID: 28605431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
    Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N
    Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.
    Aaron SD; Ferris W; Ramotar K; Vandemheen K; Chan F; Saginur R
    J Clin Microbiol; 2002 Nov; 40(11):4172-9. PubMed ID: 12409393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
    Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Three Self-Secreted Biofilm Exopolysaccharides of
    Chung J; Eisha S; Park S; Morris AJ; Martin I
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies.
    Høiby N
    J Cyst Fibros; 2002 Dec; 1(4):249-54. PubMed ID: 15463822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
    Kobayashi H
    Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iron uptake and biofilm formation in Pseudomonas aeruginosa].
    Yu S; Ma L
    Sheng Wu Gong Cheng Xue Bao; 2017 Sep; 33(9):1489-1512. PubMed ID: 28956396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
    Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
    APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.
    Singh PK; Schaefer AL; Parsek MR; Moninger TO; Welsh MJ; Greenberg EP
    Nature; 2000 Oct; 407(6805):762-4. PubMed ID: 11048725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.